U.S. Infectious Diseases: Sexually Transmitted Disease Diagnostics Markets - Market Research Reports - Research and Markets

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/358090

U.S. Infectious Diseases: Sexually Transmitted Disease Diagnostics Markets

Description:

Limited Awareness of Sexually Transmitted Diseases Stunts the Growth of a Dynamic Market

The asymptomatic nature of many sexually transmitted diseases (STDs) retards growth of the infectious disease diagnostic markets. Individuals generally undergo screening only if signs and symptoms of infection surface, which minimizes routine, voluntary screening. The Center for Disease Control estimates that nearly 3.9 million Americans have been infected with hepatitis C virus (HCV), and 25,000 individuals are diagnosed with hepatitis C annually. Yet, identification is prevented by the fact that nearly 80 percent of those infected have few if any signs or symptoms. Only the human immunodeficiency virus (HIV) has remained in the spotlight through educational initiatives, but other diseases have not had this kind of media attention that results in support and prevention.

This new research from Frost & Sullivan analyzes the U.S. Infectious Disease Diagnostics Markets, segmented as follows: HIV, HCV, Chlamydia/Gonorrhea, and the emerging market, Human Papilloma Virus diagnostics. The report provides strategic analysis and forecasts, discusses drivers and restraints, competitive environment, and industry trends.

Novel Technologies and Diagnostic Products Significantly Impact Healthcare and Create Niche Markets

The adaptation of existing technologies and the development of novel assays will drive the infectious disease diagnostics market in the future, says the analyst of this report. An increased level of response from the industry to deal with emerging infectious disease agents has created methods such as HIV and HCV genotyping. This has been cited as an important tool for recognizing the strains of virus that will be responsive to treatment.

The availability and efficacy of antiviral treatment, such as drug cocktails, has significantly prolonged the life expectancy of persons diagnosed with HIV. This has led to a growing population of patients that require routine viral monitoring to gauge treatment effectiveness. Companies are expected to increase revenues with the introduction of expanded testing menus, including West Nile Virus and Parvo assays.

Technological Innovation of Molecular Diagnostic Products Drives Sales

The specificity of molecular diagnostic products, and the added information they provide encourages their use as confirmatory and supplemental tests. Growing acceptance and employment of these diagnostic assays is expected to contribute directly to the increase in revenues.

Molecular diagnostic methods have also been used to detect different strains of HIV (genotyping), and can aid therapy by monitoring the effectiveness of treatment through observation of a patients viral load over time. The remarkable sensitivity of molecular tests makes them ideal for blood screening, however; the lack of full automation and cost-related issues have contributed to the continued reliance on immunological testing methods. The developing SARS outbreak, coupled with the need for identifying emerging diseases, signifies a growing need for both testing platforms.

Additional InformationThe following technologies are covered in this report

Genotyping: A method for studying and monitoring the changes in genetic information, a genome-wide approach to gene mapping.

Viral Load Monitoring: A method of determining the concentration of virus in a patient’s blood.

Immunoassays: A test that utilizes antibodies to detect the presence of a specific protein, such as a hormone or virus particle.

Molecular Diagnostics: Assays and tests that detect the DNA or RNA for the purpose of diagnosis.

Contents:

1 U.S. INFECTIOUS DISEASES,
  Executive Summary
      1. Executive Summary

  2 U.S. INFECTIOUS DISEASES, TOTAL MARKET

  Market Overview
      1. Introduction
      2. Analysis
      3. Research Methodology

  Competitive Structure and Revenue Forecast
      1. Market Segmentation
      2. Revenue Forecast

  Challenges and Strategies
      1. Market Challenges
      2. Strategic Recommendations

  Awards
      1. Product Leadership
      2. Product Innovation Award
      3. Technology Leadership
      4. Technology Innovation Award

  3 U.S. INFECTIOUS DISEASES, HIV DIAGNOSTICS MARKET

  Market Overview
      1. Introduction
      2. Market Drivers
      3. Market Restraints
      4. Scope and Definition

  Product Analysis and Market Trends
      1. Market and Technology Trends
      2. Immunodiagnostic Products
      3. Molecular Diagnostic Products

  Competitive Analysis and Revenue Forecast
      1. Competitive Structure
      2. Market Share Analysis
      3. Revenue Forecast

  4 U.S. INFECTIOUS DISEASES, HEPATITIS C DIAGNOSTICS MARKET

  Market Overview
      1. Introduction
      2. Market Drivers
      3. Market Restraints
      4. Scope and Definition

  Product Analysis and Market Trends
      1. Market and Technology Trends
      2. Immunodiagnostic Products
      3. Molecular Diagnostic Products

  Competitive Analysis and Revenue Forecast
      1. Competitive Structure
      2. Market Share Analysis
      3. Revenue Forecast

  5 U.S. INFECTIOUS DISEASES, CHLAMYDIA AND GONORRHEA DIAGNOSTICS MARKET

  Market Overview
      1. Introduction
      2. Market Drivers
      3. Market Restraints
      4. Scope and Definition

  Product Analysis and Market Trends
      1. Market and Technology Trends
      2. Diagnostic Products

  Competitive Analysis and Revenue Forecast
      1. Competitive Structure
      2. Market Share Analysis
      3. Revenue Forecast

  6 U.S. INFECTIOUS DISEASES, EMERGING MARKET

  Human Papilloma Virus (HPV)
      1. Introduction
      2. Market Potential
      3. Diagnostic Solutions

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/358090

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 13/02/2012 03:36:41

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.


Product Name:
U.S. Infectious Diseases: Sexually Transmitted Disease Diagnostics Markets
Web Address:
http://www.researchandmarkets.com/reports/358090
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic - Site License		€3,019.00
	Electronic - Enterprisewide		€4,165.00
	Electronic and Hard Copy (PDF) - Enterprisewide		€4,547.00 + EUR€ 50.00 Shipping/Handling *
	Electronic and Hard Copy (PDF) - Site License		€3,401.00 + EUR€ 50.00 Shipping/Handling *

* Shipping/Handling is only charged once per order.

Contact information
Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed 13/02/2012 03:36:41

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder's Name:

Cardholder's Signature:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)